Rubius Therapeutics Inc (fka RUBY)

[Frankestin]

On December 6, 2022, Rubius Therapeutics, Inc. (the “Company”), entered into a Purchase and Sale Agreement (the “Agreement”) with DIV Acquisition V, LLC (the “Buyer”) for the sale of certain real property located at 100 Technology Way, Smithfield, Rhode Island 02917 (Map 49, Lot 219) and 30 Hanton City Road, Smithfield, Rhode Island 02917 (Map 49, Lot 78), together with the buildings and improvements, including the Company's manufacturing facility, and certain fixtures and personal property located in or on the real property, for an aggregate purchase price of $18,500,000, subject to adjustment. The transaction, which is subject to customary closing conditions, is expected to close on December 21, 2022.

MC 15 millions